My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 105

    1.

    Impaired mitochondrial function and insulin resistance of skeletal muscle in mitochondrial diabetes.

    Szendroedi J, Schmid AI, Meyerspeer M, Cervin C, Kacerovsky M, Smekal G, Gräser-Lang S, Groop L, Roden M.

    Diabetes Care. 2009 Apr;32(4):677-9. Epub 2009 Jan 8.PMID: 19131470 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents.

    Petersen KF, Dufour S, Shulman GI.

    PLoS Med. 2005 Sep;2(9):e233. Epub 2005 Aug 16.PMID: 16089501 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes.

    Szendroedi J, Schmid AI, Chmelik M, Toth C, Brehm A, Krssak M, Nowotny P, Wolzt M, Waldhausl W, Roden M.

    PLoS Med. 2007 May;4(5):e154.PMID: 17472434 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.

    Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI.

    N Engl J Med. 2004 Feb 12;350(7):664-71.PMID: 14960743 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects.

    Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, Jeneson JA, Backes WH, van Echteld CJ, van Engelshoven JM, Mensink M, Schrauwen P.

    Diabetologia. 2007 Jan;50(1):113-20. Epub 2006 Nov 9.PMID: 17093944 [PubMed - indexed for MEDLINE]Related articles

    6.

    Multitissue insulin resistance despite near-normoglycemic remission in Africans with ketosis-prone diabetes.

    Choukem SP, Sobngwi E, Fetita LS, Boudou P, De Kerviler E, Boirie Y, Hainault I, Vexiau P, Mauvais-Jarvis F, Calvo F, Gautier JF.

    Diabetes Care. 2008 Dec;31(12):2332-7. Epub 2008 Sep 22.PMID: 18809633 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance.

    Nair KS, Bigelow ML, Asmann YW, Chow LS, Coenen-Schimke JM, Klaus KA, Guo ZK, Sreekumar R, Irving BA.

    Diabetes. 2008 May;57(5):1166-75. Epub 2008 Feb 19. Erratum in: Diabetes. 2009 Mar;58(3):770. PMID: 18285554 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults.

    Fleischman A, Johnsen S, Systrom DM, Hrovat M, Farrar CT, Frontera W, Fitch K, Thomas BJ, Torriani M, Côté HC, Grinspoon SK.

    Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1666-73. Epub 2007 Feb 6.PMID: 17284576 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Reduced basal ATP synthetic flux of skeletal muscle in patients with previous acromegaly.

    Szendroedi J, Zwettler E, Schmid AI, Chmelik M, Pacini G, Kacerovsky G, Smekal G, Nowotny P, Wagner O, Schnack C, Schernthaner G, Klaushofer K, Roden M.

    PLoS One. 2008;3(12):e3958. Epub 2008 Dec 18.PMID: 19093000 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Mitochondrial function in skeletal muscle is normal and unrelated to insulin action in young men born with low birth weight.

    Brøns C, Jensen CB, Storgaard H, Alibegovic A, Jacobsen S, Nilsson E, Astrup A, Quistorff B, Vaag A.

    J Clin Endocrinol Metab. 2008 Oct;93(10):3885-92. Epub 2008 Jul 15.PMID: 18628517 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle.

    Brehm A, Krssak M, Schmid AI, Nowotny P, Waldhäusl W, Roden M.

    Diabetes. 2006 Jan;55(1):136-40.PMID: 16380486 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    m.3243A>G mutation in mitochondrial DNA leads to decreased insulin sensitivity in skeletal muscle and to progressive beta-cell dysfunction.

    Lindroos MM, Majamaa K, Tura A, Mari A, Kalliokoski KK, Taittonen MT, Iozzo P, Nuutila P.

    Diabetes. 2009 Mar;58(3):543-9. Epub 2008 Dec 10.PMID: 19073775 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The role of intramyocellular lipids during hypoglycemia in patients with intensively treated type 1 diabetes.

    Bernroider E, Brehm A, Krssak M, Anderwald C, Trajanoski Z, Cline G, Shulman GI, Roden M.

    J Clin Endocrinol Metab. 2005 Oct;90(10):5559-65. Epub 2005 Jul 5.PMID: 15998784 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The insulin-sensitizing effect of rosiglitazone in type 2 diabetes mellitus patients does not require improved in vivo muscle mitochondrial function.

    Schrauwen-Hinderling VB, Mensink M, Hesselink MK, Sels JP, Kooi ME, Schrauwen P.

    J Clin Endocrinol Metab. 2008 Jul;93(7):2917-21. Epub 2008 May 6.PMID: 18460571 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle.

    Anderwald C, Bernroider E, Krssak M, Stingl H, Brehm A, Bischof MG, Nowotny P, Roden M, Waldhäusl W.

    Diabetes. 2002 Oct;51(10):3025-32.PMID: 12351443 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Paradoxical effects of increased expression of PGC-1alpha on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism.

    Choi CS, Befroy DE, Codella R, Kim S, Reznick RM, Hwang YJ, Liu ZX, Lee HY, Distefano A, Samuel VT, Zhang D, Cline GW, Handschin C, Lin J, Petersen KF, Spiegelman BM, Shulman GI.

    Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19926-31. Epub 2008 Dec 9.PMID: 19066218 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.

    Pratipanawatr T, Pratipanawatr W, Rosen C, Berria R, Bajaj M, Cusi K, Mandarino L, Kashyap S, Belfort R, DeFronzo RA.

    Am J Physiol Endocrinol Metab. 2002 Jun;282(6):E1360-8.PMID: 12006367 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects.

    Jacob S, Machann J, Rett K, Brechtel K, Volk A, Renn W, Maerker E, Matthaei S, Schick F, Claussen CD, Häring HU.

    Diabetes. 1999 May;48(5):1113-9.PMID: 10331418 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes.

    Perseghin G, Lattuada G, De Cobelli F, Esposito A, Costantino F, Canu T, Scifo P, De Taddeo F, Maffi P, Secchi A, Del Maschio A, Luzi L.

    Diabetologia. 2005 Dec;48(12):2615-21. Epub 2005 Nov 1.PMID: 16261312 [PubMed - indexed for MEDLINE]Related articles

    20.

    Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes.

    Levin K, Daa Schroeder H, Alford FP, Beck-Nielsen H.

    Diabetologia. 2001 Jul;44(7):824-33.PMID: 11508266 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity